trial · primary record
Guselkumab Dose 1
Crohn's Disease
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 1409 |
| Primary completion | 2028-01-28 |
| Primary endpoint | GALAXI 1: Change From Baseline in the Crohn's Disease Activity Index (CDAI) Score at Week 12 |
| Registry ID | NCT03466411 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:44.349Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03466411
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.